☆ 4.7 Article

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer

Journal for ImmunoTherapy of Cancer (2014)

Journal

Journal for ImmunoTherapy of Cancer

Volume 2, Issue Suppl 3, Pages P83

Publisher

Springer Nature

DOI: 10.1186/2051-1426-2-s3-p83

Keywords

-

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.